118 related articles for article (PubMed ID: 38458171)
21. Controllable genome editing with split-engineered base editors.
Berríos KN; Evitt NH; DeWeerd RA; Ren D; Luo M; Barka A; Wang T; Bartman CR; Lan Y; Green AM; Shi J; Kohli RM
Nat Chem Biol; 2021 Dec; 17(12):1262-1270. PubMed ID: 34663942
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
Anello R; Cohen S; Atkinson G; Hall SJ
J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
[TBL] [Abstract][Full Text] [Related]
23. The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.
Haché G; Liddament MT; Harris RS
J Biol Chem; 2005 Mar; 280(12):10920-4. PubMed ID: 15647250
[TBL] [Abstract][Full Text] [Related]
24. Genetic evidence for a repressor of synthesis of cytosine deaminase and purine biosynthesis enzymes in Escherichia coli.
Kilstrup M; Meng LM; Neuhard J; Nygaard P
J Bacteriol; 1989 Apr; 171(4):2124-7. PubMed ID: 2539360
[TBL] [Abstract][Full Text] [Related]
25. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
[TBL] [Abstract][Full Text] [Related]
26. High-efficiency plastome base editing in rice with TAL cytosine deaminase.
Li R; Char SN; Liu B; Liu H; Li X; Yang B
Mol Plant; 2021 Sep; 14(9):1412-1414. PubMed ID: 34265443
[No Abstract] [Full Text] [Related]
27. A genome-phenome association study in native microbiomes identifies a mechanism for cytosine modification in DNA and RNA.
Yang W; Lin YC; Johnson W; Dai N; Vaisvila R; Weigele P; Lee YJ; Corrêa IR; Schildkraut I; Ettwiller L
Elife; 2021 Nov; 10():. PubMed ID: 34747693
[TBL] [Abstract][Full Text] [Related]
28. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
29. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
30. Cytosine deaminase MX cassettes as positive/negative selectable markers in Saccharomyces cerevisiae.
Hartzog PE; Nicholson BP; McCusker JH
Yeast; 2005 Jul; 22(10):789-98. PubMed ID: 16088873
[TBL] [Abstract][Full Text] [Related]
31. Crystallization and preliminary crystallographic analysis of yeast cytosine deaminase.
Hsu YH; Hu CY; Lin JJ; Liaw SH
Acta Crystallogr D Biol Crystallogr; 2003 May; 59(Pt 5):950-2. PubMed ID: 12777821
[TBL] [Abstract][Full Text] [Related]
32. Effect of alginate microencapsulation on the catalytic efficiency and in vitro enzyme-prodrug therapeutic efficacy of cytosine deaminase and of recombinant E. coli expressing cytosine deaminase.
Funaro MG; Nemani KV; Chen Z; Bhujwalla ZM; Griswold KE; Gimi B
J Microencapsul; 2016 Feb; 33(1):64-70. PubMed ID: 26642874
[TBL] [Abstract][Full Text] [Related]
33. Pyrimidine, purine and nitrogen control of cytosine deaminase synthesis in Escherichia coli K 12. Involvement of the glnLG and purR genes in the regulation of codA expression.
Andersen L; Kilstrup M; Neuhard J
Arch Microbiol; 1989; 152(2):115-8. PubMed ID: 2673119
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-dCas9 Mediated Cytosine Deaminase Base Editing in
Yu S; Price MA; Wang Y; Liu Y; Guo Y; Ni X; Rosser SJ; Bi C; Wang M
ACS Synth Biol; 2020 Jul; 9(7):1781-1789. PubMed ID: 32551562
[TBL] [Abstract][Full Text] [Related]
35. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
[TBL] [Abstract][Full Text] [Related]
36. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity.
Corban-Wilhelm H; Becker G; Bauder-Wüst U; Greulich D; Debus J
Clin Exp Med; 2003 Nov; 3(3):150-6. PubMed ID: 14648229
[TBL] [Abstract][Full Text] [Related]
37. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks.
Brar SS; Watson M; Diaz M
J Biol Chem; 2004 Jun; 279(25):26395-401. PubMed ID: 15087440
[TBL] [Abstract][Full Text] [Related]
38. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.
Pederson LC; Vickers SM; Buchsbaum DJ; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
J Gastrointest Surg; 1998; 2(3):283-91. PubMed ID: 9841986
[TBL] [Abstract][Full Text] [Related]
39. Evolution and diversification of lamprey antigen receptors: evidence for involvement of an AID-APOBEC family cytosine deaminase.
Rogozin IB; Iyer LM; Liang L; Glazko GV; Liston VG; Pavlov YI; Aravind L; Pancer Z
Nat Immunol; 2007 Jun; 8(6):647-56. PubMed ID: 17468760
[TBL] [Abstract][Full Text] [Related]
40. A new delivery system for 5-fluorouracil using prodrug and converting enzyme.
Akimoto M; Miyahara T; Arai J; Akimoto A; Hamada H; Yoshida Y; Yoshimura N
Br J Ophthalmol; 2002 May; 86(5):581-6. PubMed ID: 11973258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
